Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling.

Front Pharmacol · 2022 · PMC9465256 · PMID 36105202

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

Thus, the discovery of MAGL reversible inhibitors becomes a possible trend to avoid the functional antagonism of CB1R.

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.